BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Progyny (PGNY)ProgynyConference / presentation

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on

Related news

PGNYProgyny2026-01-12 13:00 EST

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

COOThe Cooper Companies2025-12-29 21:15 EST

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

COOThe Cooper Companies2025-08-14 20:15 EST

CooperCompanies to Participate in the Wells Fargo Healthcare Conference

DAREDare Bioscience, Inc.2020-02-05 13:00 EST

Daré Bioscience to Present at the 2020 BIO CEO & Investor Conference

DAREDare Bioscience, Inc.2019-09-04 12:00 EST

Daré Bioscience to Present at the H.C. Wainwright 21st Annual Global Investment Conference

TDOCTeladoc2026-03-03 21:05 EST

Teladoc Health to Participate in Upcoming Investor Conference

SERASera Prognostics2026-02-17 13:05 EST

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

TDOCTeladoc2026-03-30 20:30 EST

Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States